Imeik Technology Development (SHE:300896) subsidiary Beijing Norbot Biotechnology received a registration certificate from China's National Medical Products Administration for its lidocaine and tetracaine cream, according to an after-hours filing on Monday with the Shenzhen bourse.
The cream is an anesthetic for adults and is used in pain relief in dermal filler injections, pulsed dye laser therapy, non-ablative facial laser repair, and laser-assisted tattoo removal.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments